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Abstract  
Background: There are concerns that diminished prostaglandin action in fetal life could add 
to the risks of congenital malformations. Many endocrine disrupting chemicals have been 
found to suppress prostaglandin synthesis, but to our knowledge pesticides have never been 
tested for these effects. 
Objectives: To assess the ability of commonly used pesticides in the European Union to 
suppress prostaglandin-D2 (PGD2) synthesis. 
Methods: Changes in PGD2 secretion in juvenile mouse Sertoli cells (SC5 cells) were 
measured by using an ELISA. Co-incubations with arachidonic acid (AA) were conducted to 
elucidate the site of action in the PGD2 synthetic pathway. Molecular modelling studies were 
performed to assess whether pesticides identified as PGD2-active can be ligands of the 
cyclooxygenase (COX)2 binding pocket. 
Results: The pesticides boscalid, chlorpropham, cypermethrin, cyprodinil, fenhexamid, 
fludioxonil, imazalil, imidacloprid, iprodione, linuron, methiocarp, o-phenylphenol, 
pirimiphos-methyl, pyrimethanil and tebuconazole were found to suppress PGD2 production. 
Strikingly, some of these substances, o-phenylphenol, cypermethrin, cyprodinil, linuron and 
imazalil, showed potencies (IC50) in the range between 175 and 1500 nM, similar to those of 
analgesics intended to block COX enzymes. Supplementation with AA failed to reverse this 
effect, suggesting that the sites of action of these pesticides are COX enzymes. Molecular 
modelling studies revealed that the COX2 binding pocket can accommodate most of the 
pesticides shown to suppress PGD2 synthesis. Some of these pesticides are also capable of 
antagonising the androgen receptor. 
Conclusions: Chemicals with structural features more varied than previously thought 
suppress PGD2 synthesis. Our findings signal a need for in-vivo studies to establish the extent 
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of endocrine disrupting effects that might arise from interference with PGD2 signalling and 
androgen action simultaneously. 
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Introduction 
While the importance of androgens as drivers of male sexual differentiation in fetal life is 
widely recognised (Sharpe 2006), the involvement of prostaglandins in these processes has 
received comparatively little attention. In the 1980s, Gupta and colleagues presented 
evidence that prostaglandins play a role in the folding and fusion of the penis and scrotum 
during sexual development in mice (Gupta and Goldman 1986, Gupta and Bentlejewski 
1992). They observed that arachidonic acid (AA), a precursor of prostaglandins, can reverse 
the de-masculinising effects of the estrogen receptor agonist estradiol and the androgen 
receptor antagonist cyproterone during days 11 -14 of gestation, the time when sex 
differentiation takes place in mice. This reversal could be prevented by co-administration of 
the analgesics indomethacin and aspirin, which inhibit the cyclooxygenase (COX) reaction 
that produces prostaglandins. Gupta and colleagues concluded that testosterone drives 
embryonal sex differentiation by inducing the action of key enzymes of the AA cascade, 
phospholipases and COX isoforms (Gupta and Bentlejewski 1992). The ability of 
testosterone to induce enzymes of the arachidonic cascade, including COX, in adult rats was 
also reported by Saito et al. 1986). 
In the intervening years, Koopman and associates (Wilhelm et al. 2007) and Boizet-
Bonhoure, Poulat and colleagues (Moniot et al. 2009) elucidated the role of prostaglandins as 
a back-up mechanism for supporting the expression of the Sox9 gene (SRY box containing 
gene 9). As first suggested by Adams and McLaren (2002), prostaglandin D2 is involved in 
generating a feed-back loop to ensure male differentiation of the surrounding gonadal somatic 
cells. The proposed mechanism for this feedback loop, as detailed by Adams and McLaren 
(2002), Wilhelm et al. (2007) and Moniot et al. (2009) is as follows: Between gestational 
days 10.5 and 12, the genital ridge of male mouse embryos produces a wave of Sry (sex-
determining region on chromosome Y), thereby initiating the male differentiation pathway. 
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Sry is a transcription factor that promotes expression of the Sox9 gene (Sry box containing 
gene 9) which drives the differentiation of Sertoli cells in the genital ridge of the mouse. Only 
fully differentiated Sertoli cells can coordinate the differentiation of all other testicular cell 
types, including the androgen-producing Leydig cells. Sry and Sox9 up-regulate 
prostaglandin D2 synthase thereby promoting prostaglandin D2 (PGD2) synthesis and 
secretion. In turn, PGD2 can act via its DP receptor to upregulate Sox9 expression in an 
autocrine and paracrine manner (Adams and McLaren, 2002, Wilhelm et al. 2007 and Moniot 
et al. 2009). This PGD2 back-up mechanism ensures that cells which have failed to reach a 
critical threshold of Sry expression can still be induced to up-regulate Sox9 and subsequently 
differentiate into Sertoli cells (reviewed by Koopman 2010). Factors suppressing PGD2 
synthesis can therefore be expected to disrupt this back-up mechanism, although direct 
empirical evidence for this idea is lacking. The importance of prostaglandin signalling for 
normal testis descent recently came to light with the demonstration that mutant mice with 
PGD2 synthase knock-outs exhibited unilateral cryptorchidism (Philibert et al. 2013). 
The possibility that endocrine disruption might occur through suppression of prostaglandin 
signalling was pointed out as early as 1997 when DDE-induced eggshell thinning in raptors 
was linked to direct inhibition of prostaglandin synthesis in the shell gland mucosa, thereby 
disturbing calcium metabolism (Lundholm 1997). However, few studies had examined 
prostaglandin signalling as a target for endocrine disruption in mammalian organisms, until 
Kristensen and colleagues noticed a structural similarity between the COX inhibitor aspirin 
and certain phthalates, well-known endocrine disrupters (Kristensen et al. 2011 a b). They 
demonstrated that phenolic compounds (phthalates, benzophenones, parabens and alkyl 
phenols) and a variety of analgesics (paracetamol / acetaminophen, aspirin, ibuprofen, 
indomethacin) were capable of suppressing PGD2 and PGE2 synthesis in a mouse Sertoli cell 
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line model (SC5 cells), human mast cells and in ex vivo isolated rat testes. Inhibition of COX 
enzymes was identified as the likely mode of action for these effects. 
The possible human health consequences of suppressing prostaglandins during male sexual 
differentiation came to light in five epidemiological studies showing that the use of 
analgesics such as paracetamol by pregnant women towards the end of the first trimester and 
early in the second trimester (the proposed window of sexual differentiation in humans) is 
associated with an increased risk of testis maldescent (cryptorchidism) in their sons 
(Berkowitz and Lapinski 1996, Jensen et al. 2010, Kristensen et al. 2011a, Philippat et al. 
2012, Snijder et al. 2012). COX inhibitors such as paracetamol and aspirin were shown to 
affect the androgen-dependent anogenital index (a biomarker of insufficient androgen action) 
in the male offspring of rats dosed with paracetamol throughout gestation (Kristensen et al. 
2011a). 
Evidence from prior research suggests that suppression of prostaglandin synthesis in fetal life 
might have adverse effects on human health outcomes. We therefore investigated whether 
chemicals showing structural motifs more varied than the phenolics studied by Kristensen et 
al. (2011b) are also capable of inhibiting PGD2 synthesis. We recently reported that a number 
of widely used pesticides have androgen receptor antagonist potential in vitro and that these 
chemicals can act together when present as mixtures and also in combination with other 
antiandrogenic chemicals (Orton et al. 2011, 2012, 2013). Since mouse SC5 cells secrete 
higher levels of PGD2 than PGE2 (Kristensen et al. 2011b), we tested these pesticides for 
their ability to suppress PGD2 and investigated whether a propensity to block the androgen 
receptor might be related to PGD2 suppressing properties. We also conducted studies to 
pinpoint the likely site of action of pesticides identified as actives in the SC5 assay and 
carried out molecular modelling studies of binding to the COX-2 active site. 
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Materials and Methods 
Selection of pesticides: We selected 19 pesticides (azoxystrobin, boscalid, chlorpropham, 
chlorpyrifos, cypermethrin, cyprodinil, fenhexamid, fludioxonil, glyphosate, imazalil, 
imidacloprid, malathion, mancozeb, o-phenylphenol (OPP), pirimphos-methyl, prochloraz, 
propamocarb, pyrimethanil and thiabendazole) for in-depth studies. In view of evidence of 
their anti-androgenicity (Orton et al. 2011, Blystone et al. 2007), we added dimethomorph, 
iprodione, linuron, methiocarb and tebuconazole yielding a total of 24 pesticides selected for 
investigations of their PGD2 suppression properties in the SC5 assay. 
Chemicals: Dimethomorph and methiocarb were purchased from Greyhound 
Chromatography and Allied Chemicals (all > 98.7% pure; Birkenhead); and all other 
pesticides (all > 97% pure) were purchased from Sigma Aldrich (Poole). Ethanol (> 99.7% 
purity) was obtained from VWR International Ltd. All test compounds were dissolved in 
ethanol to prepare stock solutions (20 mM) for use in the SC5 assay. For mancozeb and 
imidacloprid, sonication had to be used to aid solubilisation.  
SC5 mouse juvenile Sertoli cell PGD2 inhibition assay: SC5 mouse juvenile Sertoli cells 
(Hofmann et al. 1992) were kindly provided by Dr Ewa Raipert-de Meyts of the Copenhagen 
Rigshospitalet, Dept of Growth and Reproduction, Denmark. We used the assay protocol 
described by Kristensen et al. (2011 b), with slight modifications. Briefly, SC5 cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM,high glucose; Sigma) with 10% 
fetal calf serum (FCS; Invitrogen Ltd), 100 U/mL penicillin, 100 µg/mL streptomycin, and 1 
mM L-glutamine (all from Sigma) at 37°C with 5% CO2. Cells were routinely passaged twice 
a week and only phthalate-free polystyrene flasks (Helena BioSciences) and 24-well plates 
(Corning; VWR) were used. Prior to each experiment, SC5 cells were seeded in 24-well 
plates (50,000 cells per well in 500 µL medium). On the next day, medium was removed and 
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400 µL fresh medium with test compound was added. Each plate contained a solvent control 
(0.5% ethanol in medium) and a positive control (1% octylphenol ethoxylate, Sigma) which 
served as a reference for cytotoxicity potentially induced by the test compounds. All 
pesticides were tested in three independent experiments and at eight different concentrations, 
with ibuprofen included in each experiment as a positive control for PGD2 suppression. 
Plates were then incubated at 37°C for 24 hours in an atmosphere of 5% CO2. At the end of 
the exposure period, 100 µL media were removed for PGD2 measurements and kept on ice. 
PGD2 levels were determined by using the prostaglandin D2-MOX enzyme immunoassay 
(EIA; Cayman Chemicals), following the manufacturer’s instructions. Plates were read at 405 
nm with a reference wave length of 620 nm (Spectramax 340 PC). PGD2 concentrations in 
samples from treated cell cultures were determined by using the linear range of a standard 
curve and were presented as percentages of the PGD2 levels measured in solvent controls. To 
correct for inter-experiment data variability, and to allow for regression analysis of pooled 
data, the PGD2 readings for the tested compounds on each EIA plate were expressed as 
percentages of the average of the values obtained from solvent controls. 
Cytotoxicity determination: After removal of aliquots of supernatant medium for PGD2 
determination, plates with SC5 cells were used for cytotoxicity testing using a modified 
version of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
(Mosmann 1983), as described by Orton et al. (2012). Data were normalised to solvent 
controls and to positive controls (1% octylphenol ethoxylate). Readings of normalised 
absorbance values below 80% of solvent controls were considered cytotoxic. 
Studies of the mode of PGD2 inhibitory action: Time series studies were conducted in which 
SC5 cells were exposed to ibuprofen (130 nM), aspirin (3400 nM) and ortho-phenylphenol 
(OPP, 175 nM) for 5 min, 15 min, 30 min, 1hr, 2hr, 3hr, 6hr and 24 hr (3 experiments 
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performed in duplicate). The selected concentrations corresponded to half-maximal 
suppressions of PGD2 levels (IC50), as determined in concentration-response analyses for the 
full duration of exposure (24 hr) in the SC5 assay. 
We assessed the mode of action of OPP by comparison to ibuprofen, aspirin and the 
phospholipase A2 inhibitor MJ33 in terms of the reversibility of PGD2 inhibition and the 
influence of arachidonic acid (AA) on PGD2 levels. SC5 cells were exposed to ibuprofen (10 
µM), aspirin (100 µM), OPP (10 µM) or the phospholipase A2 inhibitor (PLI) MJ33 (100 
µM, Sigma) for 4 hours. After 4 hours, medium was processed for PGD2 measurements, as 
described. Some cultures received one of the following treatments for a further 2 hours: (a) 
treatment medium was removed and cells were washed with HBSS, followed by addition of 
400 µL fresh culture medium (without any of the treatment chemicals); (b) as (a) but with 
addition of culture medium (400 µL) containing 10 µM AA; (c) a small volume of AA 
solution was added to the treatment medium containing the test chemicals to make up to a 
final concentration of 10 µM. At the end of the experiments PGD2 concentrations were 
measured as described.  
The influence of AA supplementation on PGD2 levels was also studied using a wider range 
of pesticides. SC5 cells were exposed to rising concentrations of AA between 0.3 and 100 
µM for 24 hours, and 10 µM was selected for experiments with test chemicals. We exposed 
SC5 cells to varying concentrations of ibuprofen or OPP for 22 hours without AA, and then 
added AA (10 µM) for another 2 hours before the experiment was terminated. PGD2 levels 
were determined as described. The same protocol was used for nine pesticides (boscalid, 
chlorpropham, cypermethrin, cyprodinil, imazalil, imidacloprid, linuron, pirimiphos-methyl 
and tebuconazole) where each pesticide was tested at levels producing 80% (IC80) PGD2 
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suppression relative to solvent controls. These (highly effective) concentrations were chosen 
to provide decisive evidence of the effects of AA supplementation.  
Molecular modelling studies of binding to the COX2 active site: We conducted computer 
modelling studies using the software Molecular Operating Environment MOE (version 
2011.10 (Chemical Computing Group Inc., 1010 Sherbooke St. West, Suite #910, Montreal, 
QC, Canada, H3A 2R7). The crystal structure of murine COX-2, which is very similar to 
human COX-2 (Kurumbail et al. 1996), was obtained from the Research Collaboratory for 
Structural Bioinformatics (RCSB) Protein Data Bank at 2.9Å resolution (accession no. 
1PXX; primary data provided by Rowlinson et al. 2003). The monomer structure (chain A) 
was used for molecular docking, with water molecules kept. Docking studies were carried out 
by placing selected pesticides within the active site of COX-2, in a position allowing the best 
match with hydrogen bonding to Ser530 and Tyr385. A maximum of 30 positions (poses) 
was assessed for each chemical, and this proved sufficient for making judgements about 
specificity of binding. We used Andrews pKi score as an estimate of how well the selected 
pose(s) of the test chemical fit to an average binding site (MOE 2011.10). This was computed 
from the test pesticide’s structure alone, based on the physico-chemical properties (e.g. 
number of hydrogen bonds donors/acceptors, distances) without considering features of the 
COX-2 binding pocket. We also calculated a predicted pKi score, based on computed 
positions that the ligand can assume in the COX2 active site. The predicted pKi score takes 
into account the structural conformation of the test chemical and the properties of the binding 
site of the COX2. These best poses were selected based on low energy values and interactions 
within the binding site. By comparing Andrews pKi score and the predicted pKi, we judged 
whether the pesticide uses all its potential for binding in a particular position.  If the predicted 
pKi was much higher than Andrews pKi score, the ligand would appear to be specific to 
COX2.  
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Statistical analysis: For all concentration-response analyses, experiments were repeated three 
times and the data from the same test compound were pooled and nonlinear regression 
analyses performed using the best-fit approach (Scholze et al. 2001). We used a variety of 
nonlinear regression models which were fitted independently to the same data set. The best-
fitting model was selected using a statistical goodness-of-fit criterion. All statistical analyses 
were performed using SAS statistical software (SAS Institute Inc., Cary, NC, USA). From the 
regression analyses we derived estimates of IC50 (the concentration of test agent that inhibits 
the PGD2 levels by 50% compared to solvent controls. 
Results 
Suppression of prostaglandin synthesis in the SC5 mouse Sertoli cell assay. We selected 24 
pesticides (chemical structures in Supplemental Material Figure S1) to be tested in the 
present study, of which 15 (boscalid, chlorpropham, cypermethrin, cyprodinil, fenhexamid, 
fludioxonil, imazalil, imidacloprid, iprodione, linuron, methiocarp, o-phenylphenol (OPP), 
pirimiphos-methyl, pyrimethanil and tebuconazole) were found to inhibit PGD2 synthesis in 
the SC5 assay, in a concentration-dependent manner, as shown in Figure 1A-C (data and 
regression models from three independent experiments for groups of pesticides and 
ibuprofen), in Figure 1D (for OPP) and Supplemental Material Figure S2 (for the remaining 
compounds), after converting the PGD2 readings for the tested compounds on each EIA plate 
to percentages of the average values for solvents. The concentration-response relationship for 
the known non-steroidal anti-inflammatory drug ibuprofen is also shown.  
With a concentration associated with half-maximal suppression of PGD2 synthesis (IC50) of 
175 nM, the fungicide OPP was the most potent of the selected pesticides, nearly as potent as 
the analgesic ibuprofen (IC50: 128 nM) which we used as a positive control (Table 1 and 
Figure 1). Cypermethrin, an insecticide, and cyprodinil, another fungicide, were the next 
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most potent agents, with IC50 values of 678 nM and 803 nM, respectively, followed by the 
herbicide linuron (1490 nM) and the fungicide imazalil (1510 nM). The IC50 values of the 
other tested pesticides were between 1340 nM and 30.2 µM (Table 1 and Supplemental 
Material Figure S2). Cytotoxicity (MTT assay) was tested for the concentrations of test 
agents used in the SC5 assay. Cytotoxicity in the concentration ranges shown to be associated 
with suppression of PGD2 synthesis was not observed (Supplemental Material Figure S3). 
Azoxystrobin, chlorpyrifos, dimethomorph, glyphosate, malathion, mancozeb, prochloraz, 
propamocarb and thiabendazole, listed as “inactive” in Table 1, did not inhibit PGD2 
synthesis at any of the tested concentrations which ranged between 0.1 nM and 0.1 mM. 
Studies of the mode of PGD2-inhibitory action. To obtain more information about the mode 
of action by which pesticides produced PGD2 inhibition we conducted detailed experiments 
initially only with OPP, the most potent of the pesticides studied here. We compared its 
effects to ibuprofen, aspirin and the phospholipase A2 (PLA2) inhibitor MJ33. Aspirin is 
known to suppress PGD2 synthesis by irreversibly inactivating COX-1 and COX-2 through 
relatively rapid, covalent modification of the COX active site (acetylation of Ser-530), 
thereby blocking arachidonic acid (AA) binding. Ibuprofen inhibits PGD2 synthesis by 
reversible binding to the AA binding site of both COX isoforms, through competitive enzyme 
inhibition (reviewed by Blobaum and Marnett, 2007). To investigate whether OPP 
suppressed PGD2 synthesis inhibition in a manner similar to ibuprofen, or in an irreversible 
fashion akin to aspirin, we began by conducting time course studies with concentrations 
shown to induce half-maximal PGD2 suppressions after 24 hours (175 nM OPP, 128 nM 
ibuprofen and 3400 nM aspirin). After 60 minutes of incubation, aspirin reduced PGD2 levels 
to approximately 50% of control levels. OPP and ibuprofen required at least 120 minutes to 
achieve the same effect and showed almost identical time courses. By 4 hours, PGD2 levels 
had plateaued in all cases (Supplemental Material Figure S4). 
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We sought further corroboration of the mode of action of OPP by comparison also with the 
phospholipase A2 inhibitor MJ33. We treated SC5 cells for 4 hours with OPP (10 µM), 
ibuprofen (10 µM), aspirin (100 µM) or MJ33 (100 µM), removed the medium, briefly 
washed the cells and incubated with fresh medium (not containing OPP, ibuprofen, aspirin or 
MJ33) for another 2 hours. In the case of OPP and ibuprofen, the replenishment with fresh 
medium led to increases in PGD2 levels relative to cultures which had not received media 
changes at the end of the 4 hours exposure period (Figure 2 A, black bars), suggesting that 
the inhibition of COX enzymes was no longer effective. For MJ33, similar PGD2 levels were 
reached after media replenishment. In contrast, cells treated with aspirin remained unable to 
produce PGD2, due to the irreversibility of aspirin action (Figure 2 A). 
Next, we conducted experiments to assess whether the observed suppressions of PGD2 
synthesis were the consequence of blocking the release of arachidonic acid (AA) from 
phospholipids through inhibition of PLA2 (as with the PLA2 inhibitor MJ33), or by inhibition 
of COX isoforms (as with ibuprofen and aspirin). To delineate between these possibilities, we 
studied the effect of AA supplementation on PGD2 levels. In cells exposed to OPP, ibuprofen 
or MJ33, removal of the treatment media, followed by washing and addition of fresh media 
with AA (10 µM) but no test chemical, gave rise to PGD2 levels of similar magnitude, 
showing that AA could be utilized again for PGD2 production after media changes (Figure 2 
B, white bars). However, this was not the case with aspirin, where PGD2 levels remained low 
compared to solvent controls, indicating that utilization of AA was still blocked, despite 
addition of AA after removal of the drug (Fig 2 B, white bars). Finally, we added AA (10 
µM) to cultures that had been treated with all agents for 4 hours, and incubated for another 2 
hours, but this time in the presence of treatment agents. Cells exposed to OPP, ibuprofen and 
aspirin (Figure 2 B, dark grey bars) produced very small additional amounts of PGD2 
compared to the 4 hour treatment with wash-out and AA replenishment without test 
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chemicals (Figure 2 B, white bars). Their ability to utilize AA for PGD2 synthesis was 
compromised, presumably because of COX inhibition. In contrast, cells exposed to the PLA2 
inhibitor MJ33 were capable of continuing with PGD2 synthesis. The inability of AA to 
overcome the PGD2-inhibitory effects in the presence of OPP indicates that the pesticide acts 
by inhibiting COX enzymes, in a fashion similar to ibuprofen. Alternatively, it could disrupt 
the down-stream reactions that isomerise prostaglandin H2 to PGD2 and other 
prostaglandins. Had the inhibition target of OPP been upstream of the COX reaction, 
involving the release of AA from phospholipids by PLA2 , AA would have led to a recovery 
of PGD2 levels, as was observed with the PLA2 inhibitor MJ33. 
Next, we tailored our AA supplementation studies to the treatment regimen used to record the 
concentration-response relationships with pesticides over a 24 hours exposure period. 
Accordingly, we treated SC5 cells with test chemicals for 22 hours, and added AA for 
another 2 hours. Under these conditions, AA is expected to stimulate PGD2 levels only if 
COX enzymes are active, either because test chemicals act upstream of COX, e.g. on PLA2, 
or because they have degraded and thus lost their ability to inhibit COX isoforms, or because 
COX expression increased during the long incubation period. To establish an optimal AA 
concentration for these experiments, we studied the influence on PGD2 levels of rising 
concentrations of AA. After 24 hours 10 µM AA produced approximately 3-fold increases in 
PGD2 levels relative to solvent controls (Supplemental Material Figure S5). This 
concentration was selected for co-incubations with PGD2-active pesticides. When ibuprofen 
and OPP were allowed to act for 22 hours, followed by AA (10 µM) supplementation for 
another 2 hours, changes in PGD2 levels were not observed (Supplemental Material Figure 
S5), again suggesting that OPP suppresses PGD2 synthesis by inhibiting COX. 
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According to our concentration-response analyses (Figure 1, Supplemental Material Figure 
S2, Table 1), the next 9 most potent PGD2-active agents after OPP are boscalid, 
chlorpropham, cypermethrin, cyprodinil, imazalil, imidacloprid, linuron, pirimiphos-methyl 
and tebuconazole. These agents were chosen to analyse the effect of AA supplementation (for 
2 hours) following 22 hours of exposure. For each of these pesticides, concentrations 
producing 80% PGD2 suppressions relative to solvent controls (IC80) were administered to 
SC5 cells. In all cases, the addition of AA was without effect on PGD2 suppression (Figure 
3), again suggesting that the site of action is inhibition of COX isoforms. We attempted to 
corroborate this directly by utilizing COX activity assays (Cayman 700200, 760151) but 
found that these assays were insufficiently sensitive with the cell numbers accessible through 
the SC5 assay. We therefore conducted molecular modelling studies of binding to the COX2 
active site to further investigate the plausibility of COX inhibition. 
Molecular modelling studies of binding to the COX2 active site. The binding site of COX 
enzymes is a hydrophobic channel which has hydrogen bonding sites at its mouth (Tyr-355 
and Arg-120) as well as its base (Tyr-385); another possible target for hydrogen bonding is 
the acetyl salicylic acid acetylation site (Ser-530), positioned below Tyr-385 at the base of 
the channel (Kurumbail et al. 1996; Luong et al. 1996; Picot et al. 1994). We assessed by 
molecular modelling, whether pesticides capable of suppressing PGD2 would fit into the 
COX2 binding site. We approached this by comparing Andrews mean pKi scores, which 
estimate docking in a random binding site, with predicted pKi scores derived by positioning a 
pose within the COX2 binding site in a way that allows the best match with its hydrogen 
bonding sites. If the mean predicted dissociation constants (predicted pKi) scores of the 
binding of the PGD2-active pesticides are higher than the Andrews mean pKi, as with 
ibuprofen, these compounds can be fitted in the ligand binding pocket of COX2. As shown in 
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Table 2, this was the case for 13 of the 15 PGD2-active pesticides. The exceptions were 
iprodione and imidacloprid, where Andrews mean pKi was higher than the predicted pKi. 
Lack of correlation between the ability to suppress PGD2 and antagonism at the androgen 
receptor. Of the 15 pesticides identified here as capable of suppressing PGD2 synthesis, 11 
were also found to antagonise the androgen receptor in vitro (Table 1, and Orton et al. 2011). 
Only three pesticides, cypermethrin, imidacloprid and iprodione, showed activity in the SC5 
assay without also antagonising the androgen receptor (AR); boscalid was not tested for AR 
antagonism. This high concordance prompted us to investigate whether a high potency in 
PGD2 suppression is associated with strong AR antagonist potency. By collating data 
reported elsewhere (Ermler et al. 2011, Kristensen et al. 2011 b, Orton et al. 2011)  we 
identified further chemicals that were both capable of suppressing PGD2 in the SC5 assay 
and of antagonising the AR in the MDA-kb2-luc assay (Supplemental Material Table S1). 
However, plots of log IC50 (AR antagonism) versus log IC50 (PGD2 suppression) did not 
reveal a correlation between these values, suggesting that the two mechanisms are entirely 
different and not related to each other (Figure 4). 
Discussion  
We show that several pesticides currently authorised for use in the European Union have the 
ability of suppressing PGD2 synthesis in vitro. Strikingly, some of these substances, OPP, 
cypermethrin, cyprodinil, linuron, tebuconazole and imazalil, showed potencies (IC50) in the 
range between 175 and 2300 nM (Figure 1, Table 1), comparable with those measured for 
some analgesics intended to inhibit COX enzymes, including ibuprofen (128 nM) and aspirin 
(5380 nM). 
In principle, these PGD2 suppressing effects can arise from inhibition of multiple elements of 
the AA cascade, including phospholipase A2, COX enzymes which produce PGH2, and the 
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downstream reactions which convert PGH2 into PGD2. Our observation that AA 
supplementation failed to rescue the PGD2-inhibiting effects of our test compounds suggests 
that the site of action can be narrowed down to COX inhibition and/or the down-stream 
events involving PGH2 conversion to PGD2. Inhibition of PGD2 synthesis could also be a 
consequence of down-regulation of COX enzyme expression, but this possibility was shown 
not to apply to various endocrine disrupting chemicals (Kristensen et al. 2011 b). Our results 
provide further evidence that COX down-regulation does not play a role with the chemicals 
tested here: PGD2 suppression by OPP occurs within 4 hours (Figure 2), a time frame too 
short to bring about changes in protein levels via alterations in gene expression (for which 
normally 12 – 24 hours are required, see for example Silva et al. 2010). Within 2 hours of 
removal of the chemical there was recovery from the PGD2 suppressing effects, again too 
rapid for altered mRNA levels to be responsible. 
The outcome of our docking studies also supports inhibition of COX isoforms as the most 
likely site of action. With the exception of iprodione and imidacloprid, all PGD2-suppressing 
pesticides could be fitted in the ligand binding pocket of COX2. This suggests that the PGD2-
active pesticides act by sterically hindering access of AA to the active site of COX-2 and 
perhaps also COX-1, similar to the way in which classical non-steroidal anti-inflammatory 
drugs such as ibuprofen inhibit the enzymes. Irreversible inhibition of COX enzymes, typical 
of the mode of action of aspirin, was shown not to be relevant with OPP.  
Our study demonstrates that chemicals with structural features far more varied than the 
phenolic compounds investigated by Kristensen et al. (2011 b) can inhibit PGD2 synthesis. 
While the substances identified by Kristensen et al. (2011 b) showed a terminal apolar 
benzene ring similar to aspirin or ibuprofen as a common feature, we show that pesticides 
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lacking this structural motif (pirimiphos-methyl, methiocarb, fludioxonil, imidacloprid) can 
also suppress PGD2 synthesis. 
The SC5 assay proved to be a valuable screening tool able to reveal prostaglandin 
suppressing properties of chemicals. In view of the importance of prostaglandin signalling in 
sustaining SOX9 expression and Sertoli cell differentiation (Adams and McLaren 2002, 
Moniot et al. 2009, Wilhelm et al. 2007), it can be expected that prostaglandin suppression 
early in fetal life will contribute to disruption of male sexual differentiation. The strongest 
evidence for this idea comes from observations of unilateral cryptorchidism in mice with 
PGD2 synthase knock-outs (Philibert et al. 2013). Furthermore, shortened anogenital 
distances were found in male rat offspring after in utero exposure to the COX inhibitor 
paracetamol, together with reduced PGD2 levels in rat fetal explants treated with paracetamol 
or aspirin (Kristensen et al. 2011 a).  
However, whether the pesticides investigated here will induce adverse effects in experimental 
animals related to disrupted male sexual differentiation via a PGD2-mediated mode of action 
is currently difficult to say and remains to be demonstrated. This will depend on factors that 
cannot be captured by the SC5 assay, including time of exposure, transport, systemic 
circulation and metabolism. It is possible that rapid metabolism and other toxicokinetic 
factors ensure that many of the PGD2-active pesticides will not reach effective tissue levels, 
so that adverse effects cannot materialise in vivo at dosages tolerated by the experimental 
animals. It is also unclear whether the possible adverse developmental effects of 
prostaglandin suppression that arise from exposure in fetal life are limited to the reproductive 
system. Several other cell types, including endocrine active cells in the pancreas and 
endocrine active mesenchymal cells such as adipocytes are derived from the same 
mesenchymal stem cells as Leydig cells. If these are also susceptible to prostaglandin 
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signalling, effects beyond the reproductive system may arise, but this has remained largely 
unexplored.  
Associations between exposure to mild analgesics in pregnancy and congenital 
malformations such as cryptorchidism or hypospadias have been reported based on 
observational epidemiological studies (Jensen et al. 2010, Kristensen et al. 2011a, Philippat et 
al. 2012, Snijder et al. 2012) However, whether these effects can be attributed solely to COX 
inhibition is unclear since paracetamol and its metabolite were shown to also suppress 
production of InsL3, the hormone responsible for the first phase of testis descent (Mazaud-
Guittot et al. 2013). Recent studies show that PGD2 is involved in suppressing cell invasion 
and metastasis in testis cancer cells (Shyu et al. 2013, Wu et al. 2012). 
We are able to pinpoint chemicals capable of suppressing PGD2 synthesis and blocking the 
AR at the same time, thereby affecting several mechanisms and modalities relevant to male 
sexual differentiation. Most of the PGD2 inhibiting pesticides (11 out of 15, Table 1 and 
Supplemental Material Table 1) fall into this category. It will be interesting to assess the 
consequences of such multiple modes of action in vivo as no relevant data regarding 
disruption of male sexual differentiation by such multiple modalities are available in the peer-
reviewed literature. Conversely, the pesticides with PGD2-suppressing properties, but lacking 
AR antagonistic effects (cypermethrin, imidacloprid and iprodione) may provide tools useful 
for disentangling the relative importance of prostaglandin synthesis inhibition in producing 
adverse male reproductive effects. The lack of correlation between the potency in suppressing 
PGD2 and antagonising the androgen receptor (Figure 4) suggests that such dual activities are 
coincidental, and are not linked in any mechanistic way. 
OPP, the most potent PGD2 suppressing agent tested here, is an antimicrobial agent used as 
fungicide and sanitizer, for example on pears and citrus fruits. The available data suggest that 
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exposure to this pesticide is widespread, albeit at low levels. It was detected in 40 of 60 
different canned beers at concentrations in the low parts per billion (Coelhan et al., 2006) and 
in all human urine samples tested in two studies (Bartels et al. 1997, Ye et al. 2005), in 85% 
of breast milk samples (Ye et al. 2006) and 30% of amniotic fluid samples (Bradman et al. 
2003) in the United States. 
Taken together, our findings support concerns that chronic exposure to multiple endocrine 
disrupters which interfere with PGD2 signalling and diminish androgen action, together with 
episodes of high exposures to mild analgesics during pregnancy may pose previously 
unrecognised risks. We have recently shown that paracetamol and other antiandrogens can 
act together to produce demasculising effects in male rats after in utero exposure 
(Christiansen et al. 2012). The likely effects on humans are more difficult to anticipate at 
present. The results of these studies support the need to evaluate the effects of pesticides on 
PGD2 synthesis in vivo.   
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Table 1: List of chemicals tested for PGD2 synthesis inhibition in mouse Sertoli cells. IC50 
values are shown for pesticides found to inhibit PGD2 synthesis.  
Pesticides Use PGD2 inhibition 
(IC50 in nM) 
AR antagonism 
(IC50 in nM, 
Orton et al. 
2011) 
Mancozeb   Fungicide inactive inactive 
Cyprodinil  Fungicide 803 28100 
Imazalil  Fungicide 1510 8300 
Pirimphos-methyl  Insecticide 2140 17100 
Pyrimethanil  Fungicide 8270 98600 
Thiabendazole   Fungicide inactive inactive 
Malathion  Insecticide inactive inactive 
Imidacloprid  Insecticide 4450 inactive 
Fludioxonil  Fungicide 30200 2620 
Azoxystrobin  Fungicide inactive inactive 
Fenhexamid  Fungicide 7370 7080 
Iprodione   Fungicide 25200 inactive 
Propamocarp   Fungicide inactive inactive 
Chlorpyrifos   Insecticide inactive inactive 
Chlorpropham  Herbicide 1340 19200 
O-Phenylphenol  Fungicide 175 9570 
Cypermethrin  Insecticide 678 inactive 
Boscalid   Fungicide 1550 Not tested 
Glyphosate   Herbicide inactive inactive 
Prochloraz  Fungicide inactive 6030 
Methiocarb  Insecticide 7850 14800 
Tebuconazole  Fungicide 2320 8060 
Dimethomorph  Fungicide inactive 940 
Linuron  Herbicide 1490 6630 
Ibuprofen NSAID 128 inactive 
Aspirin NSAID 3426 inactive 
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Table 2: Results of modelling studies of docking of pesticides into the active site of COX-2 
Chemical Andrews 
mean pKi1 
Predicted pKi2 Hydrogen 
bonds 
Hydrophobic 
interaction 
diff between 
predicted pKi 
and Andrews 
mean pKi 
Ibuprofen -5.26 4.35 0.56 3.06 9.61 
o-Phenylphenol -3.29 4.94 0.13 3.97 8.23 
Cypermethrin 0.43 9.14 0.2 8.83 8.71 
Cyprodinil -1.68 4.53 0 4.13 6.21 
Linuron -0.87 4.92 0.64 3.44 5.79 
Imazalil -1.46 4.17 0.24 3.82 5.63 
Chlorpropham -4.61 4.12 0.19 3.09 8.73 
Boscalid 3.07 6.45 0.23 6.25 3.38 
Tebuconazole 0.36 4.72 0 4.61 4.36 
Pirimphos-
methyl 
-5.05 2.63 1.01 1.51 7.68 
Imidacloprid 5.42 2.62 0.15 1.77 -2.8 
Methiocarp -4.17 3.71 0.49 2.67 7.88 
Fenhexamide 2.49 6.41 0.42 5.44 3.92 
Pyrimethanil -2.34 4.24 0 3.26 6.58 
Iprodione 6.15 4.62 0.52 3.7 -1.53 
Fludioxonil 0.21 4.15 0.01 3.44 3.94 
1 Andrews pKi is an estimate of how well the selected pose of the docked ligand can bind to the active site of 
COX-2 receptor. This is computed from ligand structure alone, without a receptor. 
2 Predicted pKi score is the predicted binding of the ligand into the COX2 active site. The value might vary 
according to the pose. The pose was selected based on low energy value and interactions within the binding site.  
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Figure Legends 
Figure 1: Suppression of PGD2 synthesis by pesticides in the mouse Sertoli cell assay. 
A-C: Best-fitting regression models for suppression of PGD2 synthesis in SC5 (mouse Sertoli) 
cells after 24 hours exposure to selected pesticides (3 replicates). Pesticides are grouped 
according to their exposure in the EU (Orton et al., 2011) in A, B and C as high, medium and 
low exposure, respectively. All data were normalised to the responses of solvent controls. 
Ibuprofen was chosen as the positive control (dashed line in A – C). D: Responses (black dots) 
and best fitting regression model with 95% confidence belts (dashed and solid red lines) for o-
phenylphenol. 
Figure 2: The mode of action of OPP in suppressing PGD2 synthesis 
A: PGD2 levels (pg/mL) after exposure of SC5 cells to solvent, OPP (10 µM), ibuprofen (IBU, 
10 µM), aspirin (ASP, 100 µM) and the phospholipase A2 inhibitor MJ 33 (100 µM) for 4 hours 
(light grey bars), or for 4 hours, followed by media exchange, a wash step and further incubation 
for 2 hours with fresh medium without test compounds (black bars). 
B: PGD2 levels in SC5 cells after exposure to the same agents as in A for 4 hours, followed by 
media exchange, a wash step and addition of AA (10 µM) without test chemicals for a further 2 
hours (white bars). Dark grey bars show PGD2 levels after treatment for 4 hours, followed by 
addition of AA to the media to give a final concentration of 10 µM and treatment with test 
chemicals for a further 2 hours. 
Environ Health Perspect DOI: 10.1289/ehp.1409544 
Advance Publication: Not Copyedited 
 
30 
 
Bars show means of three independent experiments performed in duplicate, error bars are 
standard deviations. All differences were statistically significant (t-test, p<0.01), except those 
shown for aspirin (ASP) and MJ33. 
Figure 3: The influence of AA supplementation on the PGD2-suppressing effects of selected 
pesticides 
PGD2 levels in SC5 cells exposed for 24 hours to pesticides at concentrations producing 80% 
suppression of PGD2 synthesis, with and without arachidonic acid (AA) supplementation. 
Abbreviations, with IC80, given in parenthesis: Cypm – Cypermethrin (10µM), cyp – Cyprodinil 
(10µM), Lin – Linuron (10µM), Imz- Imazalil (10µM), cpro- chlorpropham (10µM), teb – 
Tebuconozol (50 µM), imid – Imidacloprid (50 µM), Bos – Boscalid (20 µM), pmeth – 
Pirimiphosmethyl (50 µM). Comparisons are made with cells which received AA (10 µM) for 2 
hours after 22 hours of exposure to pesticides. Shown are the means of 3 experiments, error bars 
are standard deviations.  
Figure 4: Lack of correlation between the ability to suppress PGD2 synthesis and androgen 
receptor (AR) antagonist potency 
Plot showing log IC50 for AR antagonist potency (in vitro) versus log IC50 for PGD2 
suppression for ethylparaben, n-propylparaben, n-butylparaben, benzophenone 3, bisphenol A, 
flutamide, p,p-DDE, cyprodinil, imazalil, pirimiphos-methyl, pyrimethanil, fludioxonil, 
fenhexamid, chlorpropham, o-phenylphenol, methiocarb, tebuconazole and linuron.  For IC50 
values see Supplemental Material Table S1. Data are from Ermler et al. (2011), Kristensen et al. 
(2011 b), Orton et al. (2011) and the present study. 
  
Environ Health Perspect DOI: 10.1289/ehp.1409544 
Advance Publication: Not Copyedited 
 
31 
 
Figure 1. 
 
  
Environ Health Perspect DOI: 10.1289/ehp.1409544 
Advance Publication: Not Copyedited 
 
32 
 
Figure 2. 
 
  
Environ Health Perspect DOI: 10.1289/ehp.1409544 
Advance Publication: Not Copyedited 
 
33 
 
Figure 3. 
 
  
Environ Health Perspect DOI: 10.1289/ehp.1409544 
Advance Publication: Not Copyedited 
 
34 
 
Figure 4. 
 
